HBI 2023

Wednesday June 21, 2023

1:30 pmSector Analysis

Opportunities in Ophthalmology

Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations and the sector is starting to unlock the potential for multifocal lenses in middle age. Panellists include the CEO of Veonet, the largest European ophtha chain and the CEO of Opty, the largest in LatAm.

Speakers include:

Dr Markus Hamm, Group CEO, Veonet
Veonet has added a new string to its bow expanding into Spain with a recent acquisition as it’s sights turn to further European expansion and consolidation. Markus outlines the group’s strategy and integrating the different businesses.
Dr Michael Achtelik, Head of Global Key Accounts, Carl Zeiss Meditec AG
Amaury Guerrero, CEO, Opty / Patria Group
Brazil’s biggest ophthalmology group is taking the benefits of the outpatient model to grow into orthopaedics, ENT and Urology. Amaury explains the growth plans and why now is the right time to expand.
Paul Tomasic, Managing Director, Head of European Healthcare, Houlihan Lokey
Moderated by Tobias Koesters, Partner, L.E.K. Consulting



Dr Markus Hamm
Dr Markus HammGroup CEOVeonet
Dr Michael Achtelik
Dr Michael AchtelikHead of Global Key AccountsCarl Zeiss Meditec AG
Amaury Guerrero
Amaury GuerreroCEOOpty / Patria Group
Paul Tomasic
Paul TomasicManaging Director, Head of European HealthcareHoulihan Lokey
Tobias Koesters
Tobias KoestersPartnerL.E.K. Consulting

Whittle - 3rd Floor

Read more

Explore similar sessions

Final discount saving ends in...


Thank you for your interest in the HBI 2023 conference!

The event has now concluded, however feel free to explore our past event and register your interest to stay tuned for updates on next year’s conference and exciting opportunities.

We appreciate your support and look forward to seeing you soon for HBI 2024.